TYPE 1 DIABETES TRIALNET
Type 1 Diabetes TrialNet is a medical research center that preserves insulin production to prevent T1D and stop disease progression.
TYPE 1 DIABETES TRIALNET
Industry:
Biotechnology Clinical Trials Life Science Medical
Address:
Denver, Colorado, United States
Country:
United States
Website Url:
http://www.trialnet.org
Status:
Active
Contact:
+1 800 425-8361
Email Addresses:
[email protected]
Similar Organizations
Glauser Life Sciences
Glauser Life Sciences is a medical research company that researches and develops novel drug treatments for central nervous system disorders.
Intent Solutions
Intent Solutions is a medical device company that has developed a portable and programmable dispenser of prescription medications.
Midwest Clinical Research Center
Midwest Clinical Research Center is a clinical trial to study, test and develop new medication therapies for psychiatric conditions.
OnPoint
OnPoint provides clinical research staffing services to the biopharmaceutical, contract research and medical device industries.
SciMar
SciMar is a scientific research firm that focuses on pre-diabetic insulin resistance syndrome and its associated diseases work.
Stryker
Stryker is a medical technology company that offers products and services in orthopaedics.
Sun Valley Research Center
Sun Valley Research Center is a clinical research firm that helps doctors and scientists better understand, prevent, and treat diseases.
Suture Ease
Suture Ease is a medical company that develops products for laparoscopic procedures.
Terra Biological
Terra Biological is a medical research company that develops pharmaceutical compounds for well-being and stress management purposes.
Official Site Inspections
http://www.trialnet.org Semrush global rank: 2.18 M Semrush visits lastest month: 9.2 K
- Host name: 198.233.243.114
- IP address: 198.233.243.114
- Location: Minneapolis United States
- Latitude: 44.9152
- Longitude: -93.3222
- Metro Code: 613
- Timezone: America/Chicago
- Postal: 55410

More informations about "Type 1 Diabetes TrialNet"
Who We Are | TRIALNET Type 1 Diabetes TrialNet
TrialNet was established in response to the Surgeon General's Report Healthy People 2000. This report identified diabetes as a national health objective for the United States. In response, Congress created the Diabetes Research Working โฆSee details»
About Us | TRIALNET Type 1 Diabetes TrialNet
Learn about TrialNetโs mission, history and how you can help make T1D a disease of the past. Learn More. Our Support. TrialNet is supported by the National Institutes of Health, National โฆSee details»
TRIALNET - Sign In
©2023 Type 1 Diabetes TrailNet. All rights reserved.See details»
TrialNet Pathway to Prevention - Hospital for Sick Children
TrialNet Pathway to Prevention Participant Handbook www.DiabetesTrialNet.org TrialNet is a network of diabetes centers dedicated to the study, prevention, and early treatment of type 1 โฆSee details»
Participate | TRIALNET Type 1 Diabetes TrialNet
If you have any questions, please contact 800-425-8361 or email [email protected]. Thank you for your interest in participating in the Pathway to Prevention risk screening study. If you or your โฆSee details»
TrialNet Tests Family Members to Find a Cure for Type 1
Dec 13, 2018 TrialNet is an organization made up of physicians, scientists and healthcare teams at the forefront of type 1 research who are working to prevent and cure type 1 by screening family members who are living with the disease. โฆSee details»
TrialNet Locations | TRIALNET Type 1 Diabetes TrialNet
Type 1 Diabetes TrialNet; Phone: 1-800-425-8361; MON-FRI 8am-5pm ET; Contact Us. Quick Links. T1D Risk Screening; TrialNet Prevention Studies; The Stages of Type 1 Diabetes; โฆSee details»
Research4kids Site - Hospital for Sick Children
TrialNet is screening relatives of people with type 1 diabetes to find out if these family members are at risk for developing diabetes: you may be screened to determine your risk of diabetes if โฆSee details»
Online Sign-Up for TrialNet | DiaTribe
Jun 13, 2013 TrialNet is bringing their services online, making it easier for people to be screened for type 1 diabetes. Family members of those with type 1 diabetes can answer an online โฆSee details»
TrialNet Announces Type 1 Diabetes Prevention Breakthrough
Jun 9, 2019 Immune therapy delays diagnosis in people at high risk. SAN FRANCISCO & NEW YORK, JUNE 9, 2019 โ Researchers are one step closer to preventing type 1 diabetes, โฆSee details»
NIDDK Central Repository - TrialNet
Type 1 Diabetes TrialNet (TrialNet) is an international network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes. TrialNet was โฆSee details»
Type 1 Diabetes Community Celebrates Research Milestone โฆ
Nov 14, 2024 TrialNetโs mission is to prevent T1D and stop disease progression by preserving insulin production before and after diagnosis. Learn more at TrialNet.org. About Breakthrough โฆSee details»
Type 1 diabetes community celebrates research milestone during โฆ
TrialNetโs mission is to prevent T1D and stop disease progression by preserving insulin production before and after diagnosis. Learn more at TrialNet.org. About Breakthrough T1D, โฆSee details»
TrialNet Pathway | Division of Endocrinology and Diabetes
TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams at the forefront of T1D research. Our goal: a future without โฆSee details»
Participate | TRIALNET Type 1 Diabetes TrialNet
Iโd like to receive news and updates from TrialNet about important T1D research. * Required Fields. Get in Touch. Type 1 Diabetes TrialNet; Phone: 1-800-425-8361; MON-FRI 8am-5pm โฆSee details»
Frequently Asked Questions | TRIALNET Type 1 Diabetes TrialNet
TrialNet is an international network of physicians, scientists, and healthcare teams at the forefront of type 1 diabetes research. Many of us have a personal connection with type 1 diabetes โฆSee details»
Type 1 Diabetes Community Celebrates Research Milestone โฆ
Nov 25, 2024 Learn more at TrialNet.org. About Breakthrough T1D, Formerly JDRF. As the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps โฆSee details»
TrialNet Sign In
In order to comply with the General Data Protection Regulation (GDPR), we request your permission to continue to collect and store your personal data such as your name and contact โฆSee details»
Teplizumab Prevention Study | TRIALNET Type 1 Diabetes TrialNet
TrialNet Chair Kevan C. Herold, M.D., Yale University, served as TrialNet Principal Investigator for the study that spanned 10 years. โWe want to thank TrialNet research teams and participants โฆSee details»